AIM： To evaluate portal hypertension parameters in liver cirrhosis patients with and without esophageal varices （EV）. METHODS： A cohort of patients with biopsy confirmed liver cirrhosis was investigated endoscopic...AIM： To evaluate portal hypertension parameters in liver cirrhosis patients with and without esophageal varices （EV）. METHODS： A cohort of patients with biopsy confirmed liver cirrhosis was investigated endoscopically and with color Doppler ultrasonography as a possible noninvasive predictive tool. The relationship between portal hemodynamics and the presence and size of EV was evaluated using uni- and multivariate approaches. RESULTS： Eighty five consecutive cirrhotic patients （43 men and 42 women） were enrolled. Mean age （± SD） was 47.5 （± 15.9）. Portal vein diameter （13.88 ± 2.42 vs 12.00 ± 1.69, P 〈 0.0005） and liver vascular index （8.31 ± 2.72 vs 17.8 ± 6.28, P 〈 0.0005） were found to be significantly higher in patients with EV irrespective of size and in patients with large varices （14.54 ± 1.48 vs 13.24 ± 2.55, P 〈 0.05 and 6.45 ± 2.78 v$10.96 ± 5.05, P 〈 0.0005, respectively）, while portal vein flow velocity （13.25 ± 3.66 vs 20.25 ± 5.05, P 〈 0.0005）, congestion index （CI） （0.11 ± 0.03 vs 0.06 ± 0.03, P 〈 0.0005）, portal hypertensive index （2.62 ± 0.79 vs 1.33 ± 0.53, P 〈 0.0005）, and hepatic （0.73 ± 0.07 vs 0.66 ± 0.07, P 〈 0.001） and splenic artery resistance index （R/） （0.73 ± 0.06 vs 0.62 ± 0.08, P 〈 0.0005） were significantly lower. A logistic regression model confirmed spleen size （P = 0.002, AUC 0.72） and portal hypertensive index （P = 0.040, AUC 0.79） as independent predictors for the occurrence of large esophageal varices （LEV）. CONCLUSION： Our data suggest two independent situations for beginning endoscopic evaluation of compensated cirrhotic patients： Portal hypertensive index 〉 2.08 and spleen size 〉 15.05 cm. These factors may help identifying patients with a low probability of LEV who may not need upper gastrointestinal endoscopy.展开更多
Background：Cerebral hyperperfusion syndrome is an important complication of carotid endarterectomy （CEA）.An 〉 100% increase in middle cerebral artery velocity （MCAV） after CEA is used to predict the cerebral hyp...Background：Cerebral hyperperfusion syndrome is an important complication of carotid endarterectomy （CEA）.An 〉 100% increase in middle cerebral artery velocity （MCAV） after CEA is used to predict the cerebral hyperperfusion syndrome （CHS） development,but the accuracy is limited.The increase in blood pressure （BP） after surgery is a risk factor of CHS,but no study uses it to predict CHS.This study was to create a more precise parameter for prediction of CHS by combined the increase of MCAV and BP after CEA.Methods：Systolic MCAV measured by transcranial Doppler and systematic BP were recorded preoperatively;30 min postoperatively.The new parameter velocity BP index （VBI） was calculated from the postoperative increase ratios of MCAV and BE The prediction powers of VBI and the increase ratio of MCAV （velocity ratio [VR]） were compared for predicting CHS occurrence.Results：Totally,6/185 cases suffered CHS.The best-fit cut-off point of 2.0 for VBI was identified,which had 83.3% sensitivity,98.3% specificity,62.5% positive predictive value and 99.4% negative predictive value for CHS development.This result is significantly better than VR （33.3%,97.2%,28.6% and 97.8%）.The area under the curve （AUC） of receiver operating characteristic：AUCvBI =0.981,95% confidence interval [CI] 0.949-0.995;AUCvR =0.935,95% CI 0.890-0.966,P =0.02.Conclusions：The new parameter VBI can more accurately predict patients at risk of CHS after CEA.This observation needs to be validated by larger studies.展开更多
Preeclampsia is a progressive,multi-system disorder of pregnancy associated with morbidity and mortality on both the mother and the fetus.Currently,research is directed at identifying early biomarkers of preeclampsia ...Preeclampsia is a progressive,multi-system disorder of pregnancy associated with morbidity and mortality on both the mother and the fetus.Currently,research is directed at identifying early biomarkers of preeclampsia in order to predict its occurrence.This is important because it helps understand the pathophysiology of the disease,and thus,promises new treatment modalities.Although a clear understanding of the pathogenesis of PE remains elusive,the currently most accepted theory suggests a two-stage process.The first stage results in inadequate remodeling of the spiral arteries and leads to the second stage,whereby the clinical features of the syndrome are featured.In this review,we summarize the modalities that have been studies so far to predict preeclampsia.The use of uterine artery Doppler and several other biomarkers such as vitamin D,soluble fms-like tyrosine kinase 1/placental growth factor(sFLT1/PIGF)ratio,soluble endoglin,and a subset of T-lymphocytes has shown promising results.We are still at early stages in this advance,and no clear recommendations have been made about their clinical use to date.Further studies are still needed to improve screening strategies and evaluate the cost-effectiveness of any intervention.展开更多
基金Supported by Liver and Gastrointestinal Diseases Research Center, Tabriz University of medical sciences
文摘AIM： To evaluate portal hypertension parameters in liver cirrhosis patients with and without esophageal varices （EV）. METHODS： A cohort of patients with biopsy confirmed liver cirrhosis was investigated endoscopically and with color Doppler ultrasonography as a possible noninvasive predictive tool. The relationship between portal hemodynamics and the presence and size of EV was evaluated using uni- and multivariate approaches. RESULTS： Eighty five consecutive cirrhotic patients （43 men and 42 women） were enrolled. Mean age （± SD） was 47.5 （± 15.9）. Portal vein diameter （13.88 ± 2.42 vs 12.00 ± 1.69, P 〈 0.0005） and liver vascular index （8.31 ± 2.72 vs 17.8 ± 6.28, P 〈 0.0005） were found to be significantly higher in patients with EV irrespective of size and in patients with large varices （14.54 ± 1.48 vs 13.24 ± 2.55, P 〈 0.05 and 6.45 ± 2.78 v$10.96 ± 5.05, P 〈 0.0005, respectively）, while portal vein flow velocity （13.25 ± 3.66 vs 20.25 ± 5.05, P 〈 0.0005）, congestion index （CI） （0.11 ± 0.03 vs 0.06 ± 0.03, P 〈 0.0005）, portal hypertensive index （2.62 ± 0.79 vs 1.33 ± 0.53, P 〈 0.0005）, and hepatic （0.73 ± 0.07 vs 0.66 ± 0.07, P 〈 0.001） and splenic artery resistance index （R/） （0.73 ± 0.06 vs 0.62 ± 0.08, P 〈 0.0005） were significantly lower. A logistic regression model confirmed spleen size （P = 0.002, AUC 0.72） and portal hypertensive index （P = 0.040, AUC 0.79） as independent predictors for the occurrence of large esophageal varices （LEV）. CONCLUSION： Our data suggest two independent situations for beginning endoscopic evaluation of compensated cirrhotic patients： Portal hypertensive index 〉 2.08 and spleen size 〉 15.05 cm. These factors may help identifying patients with a low probability of LEV who may not need upper gastrointestinal endoscopy.
文摘Background：Cerebral hyperperfusion syndrome is an important complication of carotid endarterectomy （CEA）.An 〉 100% increase in middle cerebral artery velocity （MCAV） after CEA is used to predict the cerebral hyperperfusion syndrome （CHS） development,but the accuracy is limited.The increase in blood pressure （BP） after surgery is a risk factor of CHS,but no study uses it to predict CHS.This study was to create a more precise parameter for prediction of CHS by combined the increase of MCAV and BP after CEA.Methods：Systolic MCAV measured by transcranial Doppler and systematic BP were recorded preoperatively;30 min postoperatively.The new parameter velocity BP index （VBI） was calculated from the postoperative increase ratios of MCAV and BE The prediction powers of VBI and the increase ratio of MCAV （velocity ratio [VR]） were compared for predicting CHS occurrence.Results：Totally,6/185 cases suffered CHS.The best-fit cut-off point of 2.0 for VBI was identified,which had 83.3% sensitivity,98.3% specificity,62.5% positive predictive value and 99.4% negative predictive value for CHS development.This result is significantly better than VR （33.3%,97.2%,28.6% and 97.8%）.The area under the curve （AUC） of receiver operating characteristic：AUCvBI =0.981,95% confidence interval [CI] 0.949-0.995;AUCvR =0.935,95% CI 0.890-0.966,P =0.02.Conclusions：The new parameter VBI can more accurately predict patients at risk of CHS after CEA.This observation needs to be validated by larger studies.
文摘Preeclampsia is a progressive,multi-system disorder of pregnancy associated with morbidity and mortality on both the mother and the fetus.Currently,research is directed at identifying early biomarkers of preeclampsia in order to predict its occurrence.This is important because it helps understand the pathophysiology of the disease,and thus,promises new treatment modalities.Although a clear understanding of the pathogenesis of PE remains elusive,the currently most accepted theory suggests a two-stage process.The first stage results in inadequate remodeling of the spiral arteries and leads to the second stage,whereby the clinical features of the syndrome are featured.In this review,we summarize the modalities that have been studies so far to predict preeclampsia.The use of uterine artery Doppler and several other biomarkers such as vitamin D,soluble fms-like tyrosine kinase 1/placental growth factor(sFLT1/PIGF)ratio,soluble endoglin,and a subset of T-lymphocytes has shown promising results.We are still at early stages in this advance,and no clear recommendations have been made about their clinical use to date.Further studies are still needed to improve screening strategies and evaluate the cost-effectiveness of any intervention.
